Today, one third of American seniors have Alzheimer's disease or another form of dementia when they die, a trend which will result in $226 billion in medical spending in 2015 alone. These costs are likely to expand with the aging baby boom generation and ballooning medical expenses. The Atlantic will examine the social, financial and scientific challenges that treating-and ultimately curing-Alzheimer's disease poses to American society.
Since 1857, The Atlantic has helped shape the national debate on the most critical and contentious issues of our times, from politics, business, and the economy, to technology, arts, and culture. Through in-depth analysis in the monthly print magazine, complemented by up-to-the-minute insights delivered throughout the day on theatlantic.com, The Atlantic provides the nation’s thought leaders and professional class with forward-looking, fresh perspectives that provoke and challenge, define and affect the lives we’re living today, and give shape to the lives we will live tomorrow.